Sensitization of adenylate cyclase by short-term activation of 5-HT1A receptors

Cellular Signalling

Volumn 15, Issue 12, 2003, Pages 1111-1117

  Lisinicchia, Joshua G ^a   Watts, Val J ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

5 HT1A receptors; Adenylate cyclase; Heterologous sensitization; Pertussis toxin; Serotonin; Supersensitization

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENYLATE CYCLASE; BISINDOLYLMALEIMIDE; BUSPIRONE; CYCLIC AMP; CYCLOHEXIMIDE; FORSKOLIN; INDOMETACIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PERTUSSIS TOXIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; SIGNAL TRANSDUCTION;

EID: 0141541344     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(03)00115-3     Document Type: Article

References (36)

1. Dong J., deMontigny C., Blier P. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;303-311.
2. Schechter L.E., Bolanos F.J., Gozlan H., Lanfumey L., Haj-Dahmane S., Laporte A.M.et al. J. Pharmacol. Exp. Ther. 255:1990;1335-1347.
3. Hensler J.G., Durgam H. Br. J. Pharmacol. 132:2001;605-611.
4. Sim-Selley L.J., Vogt L.J., Xiao R., Childers S.R., Selley D.E. Eur. J. Pharmacol. 389:2000;147-153.
5. Newman M.E., Shapira B., Lerer B. J Pharmacol. Exp. Ther. 260:1992;16-20.
6. Hensler J.G. Neuropsychopharmacology. 26:2002;565-573.
7. Varrault A., Leviel V., Bockaert J. J Pharmacol. Exp. Ther. 257:1991;433-438.
8. LePoul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J.et al. Neuropharmacology. 39:2000;110-122.
9. Larsson L.G., Renyi L., Ross S.B., Svensson B., Angeby-Moller K. Neuropharmacology. 29:1990;85-91.
10. Li Q., Muma N.A., Battaglia G., VanDeKar L.D. J. Pharmacol. Exp. Ther. 282:1997;1581-1590.
11. Raymond J.R., Mukhin Y.V., Gettys T.W., Garnovskaya M.N. Br. J. Pharmacol. 127:1999;1751-1764.
12. Hoyer D., Clarke D.E., Fozard J.G., Hartig P.R., Martin G.R., Mylecharane E.J.et al. Pharmacol. Rev. 46:1994;157-203.
13. Nebigil C.G., Garnovskaya M.N., Casaas S.J., Mulheron J.G., Parker E.M., Gettys T.W.et al. Biochemistry. 34:1995;11954-11962.
14. Harrington M.A., Shaw K., Zhong P., Ciaranello R.D. J. Pharmacol. Exp. Ther. 268:1994;1098-1106.
15. Rotondo A., Nielsen D.A., Nakhai B., Hulihan-Giblin B., Bolos A., Goldman D. Neuropsychopharmacology. 17:1997;18-26.
16. Hensler J.G., Cervera L.S., Miller H.A., Corbitt J. J. Pharmacol. Exp. Ther. 278:1996;1138-1145.
17. Watts V.J. J. Pharmacol. Exp. Ther. 302:2002;1-7.
18. Watts V.J., Vu M.N., Wiens B.L., Jovanovic V., Van Tol H.H.M., Neve K.A. Psychopharmacology. 141:1999;83-92.
19. Hadcock J.R., Malbon C.C. J. Neurochem. 60:1993;1-9.
20. Palmer T.M., Harris C.A., Coote J., Stiles G.L. Mol. Pharmacol. 52:1997;632-640.
21. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., Vogel Z. J. Biol. Chem. 270:1995;29732-29738.
22. Watts V.J., Neve K.A. Mol. Pharmacol. 50:1996;966-976.
23. Watts V.J., Taussig R., Neve R., Neve K.A. Mol. Pharmacol. 60:2001;1168-1172.
24. Watts V.J., Wiens B.L., Cumbay M.G., Vu M.N., Neve R.L., Neve K.A. J. Neurosci. 18:1998;8692-8699.
25. Raymond J.R., Olsen C.L., Gettys T.W. Biochemistry. 32:1993;11064-11073.
26. Liu Y.F., Ghahremani M.H., Rasenick M.M., Jakobs K.H., Albert P.R. J. Biol. Chem. 274:1999;16444-16450.
27. Tso P.H., Wong Y.H. Neurosci. Lett. 299:2001;25-28.
28. Tso P.H., Wong Y.H. Mol. Neurosci. 11:2000;3213-3217.
29. Liu Y.F., Jakobs K.H., Rasenick M.M., Albert P.R. J. Biol. Chem. 269:1994;13880-13886.
30. Raymond J.R., Olsen C.L. Biochemistry. 33:1994;11264-11269.
31. Evans K.L.J., Cropper J.D., Berg K.A., Clarke W.P. J. Pharmacol. Exp. Ther. 297:2001;1025-1035.
32. Cowen D.S., Sowers R.S., Manning D.R. J. Biol. Chem. 271:1996;22297- 22300.
33. Sunahara R.K., Taussig R. Mol. Interv. 2:2002;168-184.
34. Varga E.V., Stropova D., Rubenzik M., Wang M., Landsman R.S., Roeske W.R.et al. Eur. J. Pharmacol. 348:1998;R1-R2.
35. D'Sa C., Duman R.S. Bipolar Disorders. 4:2002;183-194.
36. Neumaier J.F., Sexton T.J., Yracheta J., Diaz A.M., Brownfield M. J. Chem. Neuroanat. 21:2001;63-73.